Nalaka Gunawansa, John McCall, Stephen Munn, Peter Johnston

Slides:



Advertisements
Similar presentations
Liver Transplant Outcomes in the United States : Effect of Preservation Solution DKFC Symposium July 16, 2012 John Fung, MD, PhD Cleveland Clinic Disclosure:
Advertisements

SMALL FOR SIZE IN LIVER SURGERY Ghent, 11 th March 2005 THE HEMIPORTOCAVAL SHUNT R. Troisi, MD PhD Hepatobiliary and Liver Transplantation Service Ghent.
Optimal Graft Diameter and Location Reduces Postoperative Complications Following Total Arch Replacement with a Long Elephant Trunk K. Taniguchi K.Toda.
Northwestern University Feinberg School of Medicine New Trends in organ donation and Transplantation Juan Carlos Caicedo, MD FACS Director, Hispanic Transplant.
Management of colorectal cancer with liver metastasis Dr. Vivian Lee Department of Surgery, UCH.
What makes a pancreas allograft marginal? Peter J Friend University of Oxford.
The management of patients with CBD stone and gallstone
Classification and management of bile duct injury
Catheter-based Suture-free Hepaticojejunostomy John Seal MD Research Resident University of Chicago Department of Surgery Giuliano Testa MD Associate Professor.
ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results.
Why GIVE a Liver Transplant to Patients with GAVE Syndrome
Heart Transplantation for Patients with a Fontan Procedure
Patient Survival USA Primary DD Pancreas Transplants 1/1/2004 – 12/31/2008 Categoryn 1Yr Surv. PTA % PAK1, % SPK4, % 2/09.
L Genser (2), A Soprani(1,2), Tabbara M (2), J Cady (1) 1- Clinique Geoffroy Saint Hilaire (Paris), 2- Service de Chirurgie Digestive et Hépato-Bilio-Pancréatique,
David C. Mulligan, MD, FACS
Comparison of HTK and UW in Abdominal Transplantation Dr. Richard S. Mangus, MD MS Indiana University, School of Medicine.
Strategies for Maximizing Outcomes in Liver Transplantation James D. Eason, M.D. Chief of Transplantation / Professor of Surgery University of Tennessee.
LIVER TRANSPLANTATION- BASICS IN SURGERY
+ Liver Transplantation for PSC Patients A Transplant Surgeon’s Perspective Tiffany Anthony, MD Annette C. and Harold C. Simmons Transplant Institute Baylor.
Dr.Mohammad foudazi Research center of endoscopic surgery, Iran medical university.
1 Influence of donor & recipient risk factors and the choice of immunosuppression Long term outcome after renal transplantation Influence of donor & recipient.
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
Region 10 and In situ Split of the Deceased Donor Liver OSOTC Education Conference September 11, 2015.
Multicenter Study of Down-staging of Hepatocellular Carcinoma (HCC) to within Milan Criteria before Liver Transplantation Neil Mehta, MD; Jennifer Guy,
5-Azacitidine For Myelodysplasia Before Allogeneic Hematopoietic Cell Transplantation Field T et al. Bone Marrow Transplant 2009:[Epub ahead of print].
Andreas A. Rostved, MD Research assistant Department of Surgical Gastroenterology and Transplantation Rigshospitalet – Copenhagen University Hospital Denmark.
Professor Nigel Heaton Kings Health Partners
A CRITICAL ANALYSIS OF ORGAN PERFUSION SOLUTIONS IN LIVER TRANSPLANTATION John J. Fung, MD Director, Cleveland Clinic Health System Center for Transplantation.
Anastomosis in IBD Barry Salky, MD FACS Professor of Surgery Chief (Emeritus), Division of Laparoscopic Surgery The Mount Sinai Hospital New York.
Liver transplantation for HCV infection R3 양 인 호 /Prof 김 병 호.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
Rapid Fibrosis and Significant Histologic Recurrence of Hepatitis C After Liver Transplant Is Associated With Higher Tumor Recurrence Rates in Hepatocellular.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
OrganNumber waiting list Dec 08Number Transplant 07/08 Kidney Liver Pancreas83224 Heart Lung Total10,
Liver Transplantation in PSC: What to Know and Recent Updates Brett E. Fortune, MD, MSc Assistant Professor of Medicine and Surgery Yale School of Medicine.
Two-Stage Hepatectomy for Unresectable Metastases :
PANCREATODUODENECTOMY + MULTIVISCERAL RESECTION YES/NO
BYPASS GASTRICO DE UNA ANASTOMOSIS (OAGB-BAGUA): RESULTADOS EN UNA
The ALERT Trial.
Outcomes Monitoring of Expanded Criteria Donor (ECD)/Donor after Cardiac Death (DCD) Organs in Liver Transplantation: A Region V Transplant Program Collaborative.
Liver Transplantation – ‘who needs a liver transplant’
LOMR Portal Project Chris Marsh MD, FACS, Project Lead
  PREVENTION OF BILOMAS WITH CYANOACRYLATE-BASED SURGICAL GLUE, AFTER MAJOR LIVER RESECTION Albino V , Palaia R , di Giacomo R , Amore A , Saponara R ,
Oesophagectomy Enhanced recovery Pathway
Outcomes of bariatric surgery after renal transplant: single center experience in Kuwait Authors Gheith O, Al-Otaibi T, Nampoory MRN, Halim M, Saied T,
HCV & liver transplantation
Successful CTO PCI Associated with Lower Mortality Risk
Liver Transplantation: 50 years
Liver only transplants in the UK Question 2: In terms of survival benefit.
Biliary complications following orthotopic liver transplantation: May contrast-enhanced MR Cholangiography provide additional information?  Piero Boraschi,
(1) Donor and Transplant Activity There has been an increase in the number of liver donors since 2007/08, with a concurrent mean 12% increase in.
Preoperative tyrosine kinase inhibitors risk bowel anastomotic healing of advanced primary and recurrent/ metastatic gastrointestinal stromal tumors Jin-Chiao.
EUROPEAN LIVER TRANSPLANT REGISTRY
PREMIER: Rate of hypertension at 18 months
Risk Factors associated with Outcome
The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.
Sa1895 ENDOSCOPIC STRICTUROTOMY VS SURGICAL RE-RESECTION IN THE TREATMENT OF ANASTOMOTIC STRICTURES IN CROHN’S DISEASE  Nan Lan, Bo Shen  Gastrointestinal.
Does Liver Regeneration Increase the Postoperative HCC Recurrence after Curative Resection ? Jin-Ho Lee, MD. Department of Surgery, Yonsei University.
Stephen P. McDonald  Kidney International Supplements 
Patient characteristics: American vs Canadian transplant patients
Background Bariatric interventions offer a more efficacious and durable weight loss than non-surgical approaches Surgical weight loss procedures are limited.
Eldar Ahmadov, Mirjalal Kazimi, Kamran Beydullayev, Ceyhun Isayev, Mail Sadiyev Department of Surgery and Organ Transplantation, Central Hospital of Oil.
Pregnancy outcomes in kidney transplant recipients
Results of Living Donor Age of Sixth Decade for Adult Liver Transplantation Using a Right Lobe graft Seok-Hwan Kim.
Risk factors for postoperative infection after lower gastrointestinal surgery in patients with inflammatory bowel disease: Findings from a large epidemiological.
Axillary-Bi-Femoral and Axillary-Uni-Femoral Artery Grafts Have Similar Perioperative Outcomes and Patency Thomas W. Cheng1, M.S., Scott Hardouin1, M.D.,
Liver Transplantation for PSC in 2019
Demographic Characteristics of Cohort
Acute Rejection in ANZ TSANZ 2003
Posttransplantation cumulative survival for adult living-donor liver transplantation (LDLT) recipients without thrombotic microangiopathy (TMA; n = 220)
Presentation transcript:

Nalaka Gunawansa, John McCall, Stephen Munn, Peter Johnston BILIARY COMPLICATIONS FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION – THE NEW ZEALAND LIVER TRANSPLANT UNIT (NZLTU) EXPERIENCE Nalaka Gunawansa, John McCall, Stephen Munn, Peter Johnston

Biliary complications A major source of morbidity and graft loss Overall Incidence – 11-25% * Biliary strictures / bile leaks Strictures - Deceased donor (DDLT) – 5-15%* - Live donor (LDLT) – 28-32%* * Starzl et al. Biliary complications after liver transplantation. Surgery 1977;81:212-221 * Greif et al. The incidence, timing and management of biliary complications after OLT. Ann Surg 1994;219:40-45 * Thetyy et al. Management of biliary tract complications after OLT. Clin Transplant 2004;18:647-653

Post-OLT biliary strictures -Risk Factors Anastomotic Surgical technique Bile leaks Ischaemia – hepatic artery thrombosis / stenosis Non-anastomotic HAS/HAT Preservation injury Prolonged cold/warm ischaemia Increased donor age Chronic ductopaenic rejection DCD ABO incompatible Prolonged use of vasopressors in donor

NZLTU 1998 – 2008 (n=348) 338 patients, 348 transplants Adult (14 & above) Paediatric (<14 yrs) DWL 292 04 296 (85.06%) Partial (Split) 10 22 32 Partial (Live donor) 07 13 20 (14.94%) 309 (88.8) 39 (11.2%) Mean follow up – 57 months (5-132)

NZLTU – 1998 - 2008

Results 80 biliary complications, 70 transplants Bile Leaks (n= 17) Cut surface - 04 Anastomotic - 11 CD leak - 02 Strictures (n = 63),18.1% Anastomotic - 46 (73%) Non-anas - 09 Mixed - 08 8 of the 11 anastomotic leaks went on to develop strictures

Variables Total transplants Biliary strictures Recipient age; <14y (Overall – 18.1%) Recipient age; <14y =>14y 39 309 09 – 23.1% 54 – 17.5% Donor age; <50y =>50y 235 113 41 – 17.4% 22 – 19.5% Graft ; whole liver Partial 296 52 47 – 15.9% 16 – 30.8% Cold ischaemia; <10hrs =>10hrs 226 122 40 – 17.7% 23 – 18.9% Preservation; UW UW + arterial flush HTK 128 174 46 17 – 13.3% 33 – 19.0% 13 – 28.2% Biliary anastomosis; D-D Roux 273 75 40 – 14.7% 23 – 30.7% HA disease ; HAS/HAT + HAS/HAT - 16 332 06 – 37.5% 57 – 17.2%

Biliary anastomosis; D-D, Roux HA complications; HAS/HAT Odds ratio (95% CI) Univariate P value Multivariate Recipient age; <14, >=14 0.768 (.346 - 1.704) 0.52 0.011 Donor age; <50, >=50 1.074 (.607-1.901) 0.81 Graft; whole, partial 2.672 (1.379-5.179) 0.0036 0.0069 Isch time; <10hrs, >=10hrs 1.116 (.637-1.955) 0.70 Preservation; HTK, UW based 0.912 (.633-1.192) 0.048 0.053 Biliary anastomosis; D-D, Roux 2.716 (1.507-4.896) 0.0009 0.0018 HA complications; HAS/HAT 3.483 (1.165-9.414) 0.026 0.069

Outcome Direct Mortality – 0 Graft loss due to biliary complications– 04 (5.7%) Successful Non-operative Mx – 32 (45.7%) Re-operations – 38 (54.3%) - 04, re transplants - 01, awaiting re-transplant - 03, segmental resections - 31 biliary reconstructions

Conclusions Overall biliary complication rate – 23%, stricture rate of 18.1% The complication rates were twice as common with partial grafts (31% vs 16%) Paediatric recipients, partial grafts, associated arterial ischaemia and roux anastomoses were associated with significantly increased risk of strictures Donor age, cold ischaemia time and preservation technique did not appear to be significant Even though there was no direct mortality, 5.7% of the biliary complications resulted in graft loss Approx. 50% required surgical intervention. The remaining 50% were successfully managed with endoscopic / radiological means